Sunovion Fellowships

Sunovion, in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. A fellow gains extensive experiences through various practical activities in both industry and academic settings, which will enhance the potential for accelerated career development. The following fellowship programs are currently offered by Sunovion in collaboration with MCPHS:.

  • Scientific Communications/Medical Affairs (Recruiting)
  • Medical Information (Not recruiting)
  • Regulatory Affairs (Not recruiting)

Please see our brochure for additional details and feel free to review the content below.

Fellowship Overview

This fellowship program is designed to offer Doctor of Pharmacy graduates in-depth experience within a biopharmaceutical industry setting. In addition, PharmD graduates will have the opportunity to enhance their clinical and academic background in conjunction with MCPHS. Overall, this fellowship program will provide the training and experiences necessary to prepare the fellow for a career in the competitive pharmaceutical industry.

About Sunovion

Sunovion is a leading pharmaceutical company dedicated to discovering, developing, and commercializing therapeutic products that advance the science of medicine in the areas of psychiatry, neurology, and respiratory disease to improve the lives of patients and their families.

Sunovion brings together scientific focus, pragmatism, and dedication to research with an entrepreneurial energy and willingness to take on any challenge, always keeping the longer view in sight. We’ll continue to develop therapies in two distinct treatment areas—central nervous system disorders and respiratory ailments—as well as explore other therapeutic areas. We will continue to work with national and international partners to keep a constant stream of new drugs flowing into the pipeline. At Sunovion, we strive to serve and create value for patients every day. By developing innovative therapies that treat serious Central Nervous System (CNS) conditions, science leads the way—guiding us to a healthier tomorrow.